KBI BIOPHARMA
LIVE

Serial Number

88282125

Owner

KBI Biopharma, Inc.

Attorney

F. Michael Sajovec

First Use Date

May 1, 2012

Filing Date

Jan 30, 2019

Add to watchlist:

No watchlists yet
View on USPTO

KBI BIOPHARMA Trademark

Serial Number: 88282125 • Registration: 5839075

KBI BIOPHARMA is a trademark filed by KBI Biopharma, Inc. on January 30, 2019. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

KBI Biopharma, Inc. (9 trademarks)

1101 Hamlin Road
Durham, NC 27704

Entity Type: 03

Trademark Details

Filing Date

January 30, 2019

Registration Date

August 20, 2019

First Use Anywhere

May 1, 2012

First Use in Commerce

May 1, 2012

Published for Opposition

June 4, 2019

Goods & Services

contract manufacturing in the field of biopharmaceuticals

contract biopharmaceutical drug development services

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jan 15, 2025 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jan 15, 2025 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 15, 2025 APRE
TEAS SECTION 8 & 15 RECEIVED
Aug 21, 2024 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 20, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Aug 20, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 4, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jun 4, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 15, 2019 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 30, 2019 PREV
ASSIGNED TO LIE
Apr 29, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 16, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 16, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 16, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 16, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 16, 2019 CNEA
ASSIGNED TO EXAMINER
Apr 11, 2019 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 21, 2019 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 22, 2019 NWOS
NEW APPLICATION ENTERED
Feb 2, 2019 NWAP